The presence of active histone marks (H3K4me3 and H3K27me3) in the promoter of SFRP1 can increase the expression of SFRP1, leading to the inhibition of the Wnt signaling pathway in synovial fibroblasts in RA (98). The gene discussed is SFRP1; the disease is rheumatoid arthritis.